Oral hypoglycemic agents in pregnancy: An update

Nagandla Kavitha, Somsubhra De, Sachchithanantham Kanagasabai

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Introduction: Traditionally, insulin has been the gold standard in the management of Type 2 diabetes in pregnancy and gestational diabetes. However, insulin therapy can be inconvenient because of the needs for multiple injections, its associated cost, pain at the injection site, need for refrigeration, and skillful handling of the syringes. This has led to the exploration of oral hypoglycemic agents as an alternative to insulin therapy. Objectives: This review examines and evaluates the evidences on the efficacy, safety, and current recommendations of oral hypoglycemic agents. Conclusion: The evidence of this study supports the use of glyburide and metformin in the management of Type 2 diabetes and gestational diabetes with no increased risk of neonatal hypoglycemia or congenital anomalies. The safety of these oral hypoglycemic agents are limited to the prenatal period and more randomized controlled trials are required to provide information on the long-term follow up on neonatal and cognitive development.

Original languageEnglish
Pages (from-to)82-87
Number of pages6
JournalJournal of Obstetrics and Gynecology of India
Volume63
Issue number2
DOIs
Publication statusPublished - 01-04-2013
Externally publishedYes

Fingerprint

Hypoglycemic Agents
Gestational Diabetes
Insulin
Pregnancy
Type 2 Diabetes Mellitus
Safety
Refrigeration
Injections
Syringes
Hypoglycemia
Randomized Controlled Trials
Costs and Cost Analysis
Pain
Therapeutics

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynaecology

Cite this

Kavitha, Nagandla ; De, Somsubhra ; Kanagasabai, Sachchithanantham. / Oral hypoglycemic agents in pregnancy : An update. In: Journal of Obstetrics and Gynecology of India. 2013 ; Vol. 63, No. 2. pp. 82-87.
@article{d1d7f53a34b941d5ae0c52706f0c309a,
title = "Oral hypoglycemic agents in pregnancy: An update",
abstract = "Introduction: Traditionally, insulin has been the gold standard in the management of Type 2 diabetes in pregnancy and gestational diabetes. However, insulin therapy can be inconvenient because of the needs for multiple injections, its associated cost, pain at the injection site, need for refrigeration, and skillful handling of the syringes. This has led to the exploration of oral hypoglycemic agents as an alternative to insulin therapy. Objectives: This review examines and evaluates the evidences on the efficacy, safety, and current recommendations of oral hypoglycemic agents. Conclusion: The evidence of this study supports the use of glyburide and metformin in the management of Type 2 diabetes and gestational diabetes with no increased risk of neonatal hypoglycemia or congenital anomalies. The safety of these oral hypoglycemic agents are limited to the prenatal period and more randomized controlled trials are required to provide information on the long-term follow up on neonatal and cognitive development.",
author = "Nagandla Kavitha and Somsubhra De and Sachchithanantham Kanagasabai",
year = "2013",
month = "4",
day = "1",
doi = "10.1007/s13224-012-0312-z",
language = "English",
volume = "63",
pages = "82--87",
journal = "Journal of Obstetrics and Gynecology of India",
issn = "0971-9202",
publisher = "Springer India",
number = "2",

}

Oral hypoglycemic agents in pregnancy : An update. / Kavitha, Nagandla; De, Somsubhra; Kanagasabai, Sachchithanantham.

In: Journal of Obstetrics and Gynecology of India, Vol. 63, No. 2, 01.04.2013, p. 82-87.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Oral hypoglycemic agents in pregnancy

T2 - An update

AU - Kavitha, Nagandla

AU - De, Somsubhra

AU - Kanagasabai, Sachchithanantham

PY - 2013/4/1

Y1 - 2013/4/1

N2 - Introduction: Traditionally, insulin has been the gold standard in the management of Type 2 diabetes in pregnancy and gestational diabetes. However, insulin therapy can be inconvenient because of the needs for multiple injections, its associated cost, pain at the injection site, need for refrigeration, and skillful handling of the syringes. This has led to the exploration of oral hypoglycemic agents as an alternative to insulin therapy. Objectives: This review examines and evaluates the evidences on the efficacy, safety, and current recommendations of oral hypoglycemic agents. Conclusion: The evidence of this study supports the use of glyburide and metformin in the management of Type 2 diabetes and gestational diabetes with no increased risk of neonatal hypoglycemia or congenital anomalies. The safety of these oral hypoglycemic agents are limited to the prenatal period and more randomized controlled trials are required to provide information on the long-term follow up on neonatal and cognitive development.

AB - Introduction: Traditionally, insulin has been the gold standard in the management of Type 2 diabetes in pregnancy and gestational diabetes. However, insulin therapy can be inconvenient because of the needs for multiple injections, its associated cost, pain at the injection site, need for refrigeration, and skillful handling of the syringes. This has led to the exploration of oral hypoglycemic agents as an alternative to insulin therapy. Objectives: This review examines and evaluates the evidences on the efficacy, safety, and current recommendations of oral hypoglycemic agents. Conclusion: The evidence of this study supports the use of glyburide and metformin in the management of Type 2 diabetes and gestational diabetes with no increased risk of neonatal hypoglycemia or congenital anomalies. The safety of these oral hypoglycemic agents are limited to the prenatal period and more randomized controlled trials are required to provide information on the long-term follow up on neonatal and cognitive development.

UR - http://www.scopus.com/inward/record.url?scp=84879504623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879504623&partnerID=8YFLogxK

U2 - 10.1007/s13224-012-0312-z

DO - 10.1007/s13224-012-0312-z

M3 - Review article

AN - SCOPUS:84879504623

VL - 63

SP - 82

EP - 87

JO - Journal of Obstetrics and Gynecology of India

JF - Journal of Obstetrics and Gynecology of India

SN - 0971-9202

IS - 2

ER -